fda approval tirzepatide weight loss history The US-FDA has approved Tirzepatide for chronic management in adults with Obesity FDA Approves Zepbound: A New

These drugs may trigger brain fog and worsen general cognitive performance [11, 12, 13]

Injectables require refrigeration, which may be challenging for patients without stable housing, privacy, or climate control

For some, the FDA-approved status of a branded drug provides peace of mind

Additionally, higher doses of GLP-1 RAs (RR 1.63, 95% CI 1.112.40) and higher baseline BMI (RR 1.60, 95% CI 1.042.48) might significantly increase the risk of VAs

Excellent summary post and infographic on dietary and behavioral changes when using GLP-1 based therapies by Tom Waite The only point I would modify is the Build the Exit Strategy

Cautionary Statement Regarding Forward-Looking Statements This press release contains forward-looking statements (as that term is defined in the Private Securities Litigation Reform Act of 1995), including statements about the supply and access of Zepbound (tirzepatide) as a treatment for adults with obesity or overweight and reflects Lilly's current belief and expectations